Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Best Pract Res Clin Haematol. 2008 Jun;21(2):205–222. doi: 10.1016/j.beha.2008.02.007

Figure 1.

Figure 1

Probability of acute and chronic graft-versus-host disease (AGVHD and CGVHD) after bulk-dosing regimen (BDR) versus escalating-dose regimen (EDR) donor leukocyte infusion (DLI). Reprinted from Dazzi et al (2000, Blood 95: 67–71) with permission.